Join Our Community:
Volume 02 Issue 15
April 30, 2021
Because life depends on us™
BSMA Clearing House
for latest news and information
...at a glance
INFRASTRUCTURE NEWS!
RELEVANT ORGANIZATION NEWS!














EXECUTIVE NEWS!
The Editorial
The 100-Day Supply Chain Review, Part 3: Nearshoring vs. Offshoring
April 28, 2021

On Feb. 24, President Joe Biden signed an executive order, enforcing a 100-day review on all U.S. supply chains. This includes identifying risks for certain materials, software and pharmaceuticals. This includes reviewing transportation, production of agriculture commodities and food products. This includes assessing current domestic manufacturing workforce skills, climate change and critical goods. It also includes caring for the resilience and capacity of U.S. manufacturing supply chains.

n this 5-part series, industry experts detail the current risk areas in today’s U.S. supply chains, what should be done to address these issues, how this 100-day review will help U.S. imports/exports, address the downfalls of this 100-day review and what all of this means for the future of U.S. supply chains. CLICK HERE to read Part 1.

Moving goods and pharmaceuticals through the cold chain
The nearshoring vs. offshoring discussion has been going on for quite some time, well before the Coronavirus disease (COVID-19) made it a “thing.” Do we outsource manufacturing, or produce everything on U.S. soil? Do we import/export? And, then when something like COVID-19 hits, how does one recover goods lost in translation?

While these are all valid questions, they’re also reasons as to why a review of our nation’s supply chains is critical.
For starters, nearly 52% of organizations in India are planning a shift to nearshore locations in the wake of the COVID-19 crisis, according to a Capgemini study.
Forbes data shows that U.S. companies are leaving China for closer partnerships, especially in Mexico and Canada.
Another study reveals 76% of U.S. businesses with production in China have moved or are planning to change locations, with one-third doing so in the near future.
And, an MHI study from 2020 predicted that some organizations will choose to embrace a more regional-local sourcing, manufacturing and delivery approach, while others will look to diversify their supplier base and seek greater balance in inventory management, blending “just-in-time”

INNOVATIONS!
CHALLENGES & SOLUTIONS!















UPCOMING EVENTS:

~~~~~~~
Webinar: May 11, 2021
Clinical Forecasting and Demand Planning
for a Patient-Centric Supply Chain
Traditionally, in a push-supply chain, decisions are made based on actual patient demand to determine a bulk supply strategy at Go-Live for a clinical study. This does not account for unexpected or unknown demand or current enrollment rates, but rather based on expected enrollment. This presents challenges to supply managers to achieve accurate forecasts and leads to wasted supply from overly conservative forecasts. Additionally, this acts as a barrier to achieving a patient-centric supply chain, where supply decisions are based on longer term patient enrollment projections. So, how can we move towards a more dynamic, pull-supply chain strategy for IMP management? Hear what the experts say at this webinar!
For Details, Click Here
~~~~~~~

Visit our online Calendar for other events
~~~~~~~
BSMA USA Conference, Oct. 20
Details In Progress
Message from the BSMA Team: Please stay safe...wash your hands, don't touch any part of your face after being out and about, wear a mask to avoid touching your face or if you are coughing, keep the social distancing rule, and most of all be patient, positive, and proactive ... and we need to be kind to each other. Thank you.
Editor:
Devendra Mishra
Executive Director & Co-Founder
BSMA
+1-818-224-1552
Editor:
Dotti Yells
VP, Marketing Technology
BSMA